ADA Scientific Sessions 2026 Abstract

Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline BMI: COMBINE 1–3

By Daisuke Yabe, Raluca Maltesen, Viswanathan Mohan, Linong Ji

Trial in peopleInterventions

The paper

Daisuke Yabe, Raluca Maltesen, Viswanathan Mohan, Linong Ji

Kyoto

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1758-P

doi.org/10.2337/db26-1758-p

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial